Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2023-05-03 2023-05-01
Drug Identification Number 02230540 02230540
Brand name CLINDAMYCIN INJECTION USP CLINDAMYCIN INJECTION USP
Common or Proper name CLINDAMYCIN CLINDAMYCIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 150MG 150MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 6ML 10LIVI 6ML 10LIVI
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-03 2023-03-03
Estimated end date 2023-05-19 2023-05-19
Actual end date 2023-05-01 2023-05-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments